Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 5Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Hepatocellular 29Carcinoma, Renal Cell 17Liver Neoplasms 12Breast Neoplasms 10Carcinoma, Non-Small-Cell Lung 9Neoplasms 5Leukemia, Myeloid, Acute 5Kidney Neoplasms 5Neoplasm Metastasis 4Urinary Bladder Neoplasms 3Thyroid Neoplasms 3Prostatic Neoplasms 3Lung Neoplasms 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Lymphocytic, Chronic, B-Cell 3Colorectal Neoplasms 3Carcinoma 3Thyroid Carcinoma, Anaplastic 2Thyroid Cancer, Papillary 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Myelodysplastic Syndromes 2Multiple Myeloma 2Breast Neoplasms, Male 2Blast Crisis 2Adenocarcinoma, Follicular 2Urethral Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Thyroid cancer, medullary 1

Interventions

ixabepilone 2aldesleukin 2Oxaliplatin 2sargramostim 1rF-B7.1 vaccine 1peginterferon alfa-2b 1indolepropanol phosphate 1fludarabine phosphate 1birinapant 1becatecarin 1alvocidib 1Topotecan 1Sorafenib 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1O(6)-benzylguanine 1Nitroarginine 1Methods 1Magnetic Resonance Spectroscopy 1Lapatinib 1Interleukin-2 1Ifosfamide 1Granulocyte-Macrophage Colony-Stimulating Factor 1Gemcitabine 1Fluorodeoxyglucose F18 1Filgrastim 1Early Intervention, Educational 1Docetaxel 1Decitabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Unspecified Adult Solid Tumor, Protocol Specific × Sorafenib × Clear all
NCT00436579 2014-02-24

Sorafenib in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Terminated
110 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡